Emotion Regulation Program for Substance Use Disorders
- Sponsor
- The Catholic University of Korea
- Study ID
- NCT07698821
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Substance Use Disorder (SUD)
Eligibility Criteria
- Sex
- ALL
- Age
- 19 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Emotion Regulation Program — BEHAVIORALEight 50-minute group sessions delivered twice weekly over approximately four weeks. Session 1: understanding emotions and following the body's signals. Session 2: emotion regulation strategies I (grounding oneself through the senses when shaken). Session 3: emotion regulation strategies II (practicing choice rather than being swept away by emotion). Session 4: building a personal emotion-response scenario for moments of crisis. Session 5: facing the self-critical voice. Session 6: protecting oneself with warmth in difficult moments. Session 7: noticing and savoring positive moments. Session 8: organizing a personal emotion-regulation routine to sustain going forward. Core techniques are motivational interviewing, acceptance and commitment therapy, and group therapy, incorporating emotion-regulation and self-compassion skills.
Study Details
This study examines whether a newly developed eight-session psychosocial treatment program, called the Emotion Regulation Program, can be delivered in real-world hospital settings to people receiving inpatient care for substance use disorders in Korea, and whether it shows early signs of benefit. The program combines motivational interviewing, acceptance and commitment therapy, and group activities, and is delivered twice a week over about four weeks (eight 50-minute sessions). About 20 adults will take part at two psychiatric hospitals. Participants complete brief questionnaires and a short interview about their craving, motivation to change, difficulties in emotion regulation, self-compassion, depression, and drug use history before the program, immediately before and after each session, within one week after the program ends, and again at 1 month and 3 months after completion. After the program, some participants also join a small group discussion (focus group interview) to share their experience of the program. Because this is a small, single-group preliminary (pilot) study without a comparison group, its primary purpose is to assess feasibility, that is, whether the program and the assessment approach work well enough, and to obtain preliminary effect and variability estimates to inform the design of a future large-scale randomized controlled trial.
Key Dates
- First listed
- Jul 13, 2026
- Start date
- Sep 30, 2026
- Status verified
- Jul 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Emotion Regulation ProgramAll participants receive the Emotion Regulation Program, an eight-session group-based psychosocial treatment delivered twice weekly (50 minutes per session) over approximately four weeks. The program integrates motivational interviewing, acceptance and commitment therapy, and group therapy, and draws on emotion-regulation and self-compassion skills, covering emotional awareness, sensory grounding, choosing responses over reactions, crisis coping, self-compassion, savoring positive emotions, and a personalized emotion-regulation routine.
Primary Outcome Measure
Feasibility: Program Completion (Retention) Rate [ Time Frame: From enrollment through the end of the 8-session intervention (approximately 4 weeks) ]
Central Contacts
- Hae Kook Lee, MD, PhD+82-31-820-3050
- Hae-Ryoung Chun, PhD+82-10-6567-7833
Related Studies
- Open-Label Psilocybin Study in Transdiagnostic PopulationPHASE1 · Recruiting · Yale University · New Haven, Connecticut
- Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications.EARLY_PHASE1 · Recruiting · Medical College of Wisconsin · Milwaukee, Wisconsin
- Expanding Access to mTBI Treatment for Veterans and Service Members With Co-occurring Substance UseNot Yet Recruiting · Shepherd Center, Atlanta GA · Atlanta, Georgia
- Trauma-informed Intervention to Reduce Substance Use and to Support Community TransitionEnrolling By Invitation · Michele Staton · Frankfort, Kentucky